NCT06552819

Brief Summary

"In the context of limited accessibility to prolonged and efficient rehabilitation programs based on physical activity, this study aims to develop a home program for children with chronic diseases affecting physical health (including cerebral palsy, obesity, and neuromuscular diseases). The French company EzyGain has designed a compact treadmill equipped with sensors and a safety system, which communicates with a tablet application and a virtual reality headset to support at-home rehabilitation. This study seeks to advance the development of this solution into a prolonged and progressive training program, tailored to positively impact children's health. Future users, including children, their parents, and therapists, will be at the heart of the development process. A qualitative methodology will be employed, incorporating focus groups and a series of user experience (UX) questionnaires. The research hypothesis is that user feedbacks will enable the development of an appropriate solution that meets their specific needs and ensures high adoption rates of the device. This study is the first step before assessing the impact of the solution in these 3 groups of children (with cerebral palsy, obesity and neuromuscular disease)."

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 6, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 14, 2024

Completed
18 days until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

August 14, 2024

Status Verified

August 1, 2024

Enrollment Period

6 months

First QC Date

August 6, 2024

Last Update Submit

August 9, 2024

Conditions

Keywords

User experience, home program, treadmill, virtual reality

Outcome Measures

Primary Outcomes (1)

  • Focus group outputs

    List of topics addressed during the focus groups by patients, parents, and therapists. The topics will include: the needs and expectations of an at-home rehabilitation tool including virtual reality, perceived barriers and facilitators, and acceptability related to certain features of the solution.

    Between the second and third week

Secondary Outcomes (6)

  • User Experience Questionnaire (UEQ-S)

    Day 1 and 6 months

  • Usability Metric for User Experience (UMUX)

    Day 1 and 6 months

  • Ease with technology

    Day 1 and 6 months

  • Cybersickness

    Day 1 and 6 months

  • Children's perception of the games

    Day 1 and 6 months

  • +1 more secondary outcomes

Study Arms (1)

Children with cerebral palsy, obesity and neuromuscular disease, parents and therapists

Other: No intervention

Interventions

No intervention

Children with cerebral palsy, obesity and neuromuscular disease, parents and therapists

Eligibility Criteria

Age8 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients and parents from the active lists of medical doctors of the structures involved in the project. Therapists of the structures involved in the project.

You may qualify if:

  • aged between 8 and 18 years old
  • capable of walking during 5 minutes on a treadmill with or without walking aid, and with or without body weight support
  • diagnosis of one the following pathology: bilateral cerebral palsy, obesity, spinal muscular amiotrophy type 3, Duchenne, congenital myopathy, Charcot Marie Tooth
  • Gross Motor Function Classification System (GMFCS) I to III for the children with cerebral palsy
  • IMC superior to the centile IOTF-30 for the children with obesity
  • Functionnal level of 2 to 6 on the Walton scale, or 3 to 7 on the Vignos scale for the children with neuromuscular disease
  • \- parent of an eligible child
  • \- Therapist of at least one eligible child
  • Able to express oneself and respond to a questionnaire in French
  • Formulate their non-opposition to participate in the research

You may not qualify if:

  • Deprived of liberty by judicial or administrative decision
  • Subject to a legal protection measure"

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Angers

Angers, Maine Et Loire, 49100, France

Location

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 6, 2024

First Posted

August 14, 2024

Study Start

September 1, 2024

Primary Completion

March 1, 2025

Study Completion

May 1, 2025

Last Updated

August 14, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations